CA2462675C - Oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant - Google Patents

Oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant Download PDF

Info

Publication number
CA2462675C
CA2462675C CA2462675A CA2462675A CA2462675C CA 2462675 C CA2462675 C CA 2462675C CA 2462675 A CA2462675 A CA 2462675A CA 2462675 A CA2462675 A CA 2462675A CA 2462675 C CA2462675 C CA 2462675C
Authority
CA
Canada
Prior art keywords
group
compound
substituents
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2462675A
Other languages
English (en)
French (fr)
Other versions
CA2462675A1 (fr
Inventor
Gilles Francois Roger Guichard
Jean-Paul Briand
Vincent Semetey
Patrick Neuberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of CA2462675A1 publication Critical patent/CA2462675A1/fr
Application granted granted Critical
Publication of CA2462675C publication Critical patent/CA2462675C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
CA2462675A 2001-10-02 2002-10-02 Oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant Expired - Lifetime CA2462675C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/12659 2001-10-02
FR0112659A FR2830252B1 (fr) 2001-10-02 2001-10-02 Nouveaux oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant
PCT/FR2002/003355 WO2003029198A1 (fr) 2001-10-02 2002-10-02 Nouveaux oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
CA2462675A1 CA2462675A1 (fr) 2003-04-10
CA2462675C true CA2462675C (fr) 2013-08-27

Family

ID=8867837

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2462675A Expired - Lifetime CA2462675C (fr) 2001-10-02 2002-10-02 Oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant

Country Status (10)

Country Link
US (2) US7691899B2 (ja)
EP (1) EP1432677B1 (ja)
JP (1) JP4621426B2 (ja)
AT (1) ATE386016T1 (ja)
CA (1) CA2462675C (ja)
DE (1) DE60225031T2 (ja)
DK (1) DK1432677T3 (ja)
ES (1) ES2301691T3 (ja)
FR (1) FR2830252B1 (ja)
WO (1) WO2003029198A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2601202C (en) * 2005-03-18 2015-06-09 Centre National De La Recherche Scientifique New hybrid oligomers, their preparation process and pharmaceutical compositions containing them
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease
EP3466979B1 (en) 2013-08-21 2019-11-06 UREKA Sarl Peptide-oligourea chimeric compounds and methods of their use
WO2016207726A1 (en) * 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
WO2017037142A1 (en) 2015-08-31 2017-03-09 Centre National De La Recherche Scientifique (Cnrs) Foldamer helix bundle-based molecular encapsulation
US11267861B2 (en) 2016-04-19 2022-03-08 Ureka Sarl Peptide-oligourea foldamer compounds and methods of their use
WO2020148317A1 (en) 2019-01-18 2020-07-23 Ureka Sarl Peptide-oligourea hybrid compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE254608C (ja)
DD254319B1 (de) * 1986-12-08 1990-08-01 Fahlberg List Veb Biocide mittel auf der basis von derivaten des 2-brom-2-nitro-propan-1,3-diols
FR2788518B1 (fr) 1999-01-14 2001-03-02 Centre Nat Rech Scient Nouveaux carbamates actives stables, leur procede de preparation et leur utilisation pour la preparation d'urees

Also Published As

Publication number Publication date
US7691899B2 (en) 2010-04-06
DK1432677T3 (da) 2008-06-16
CA2462675A1 (fr) 2003-04-10
DE60225031T2 (de) 2009-07-02
US20050038105A1 (en) 2005-02-17
FR2830252A1 (fr) 2003-04-04
US20100184849A1 (en) 2010-07-22
WO2003029198A1 (fr) 2003-04-10
ES2301691T3 (es) 2008-07-01
EP1432677B1 (fr) 2008-02-13
US8071640B2 (en) 2011-12-06
DE60225031D1 (de) 2008-03-27
EP1432677A1 (fr) 2004-06-30
JP2005504122A (ja) 2005-02-10
FR2830252B1 (fr) 2005-02-04
ATE386016T1 (de) 2008-03-15
JP4621426B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
Gangloff et al. Peptoids and polypeptoids at the frontier of supra-and macromolecular engineering
Tsubery et al. Structure− function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria
Huang et al. Amphiphilic cyclic peptoids that exhibit antimicrobial activity by disrupting Staphylococcus aureus membranes
Hatai et al. Diverse properties of guanidiniocarbonyl pyrrole-based molecules: artificial analogues of arginine
Roy et al. Cyclic β-peptoids
Olsen et al. Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic α3β-tetrapeptides
US8071640B2 (en) Urea oligomers, their preparation process and pharmaceutical compositions containing them
Griglio et al. A multicomponent approach in the discovery of indoleamine 2, 3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies
EP3146981A1 (en) Covalently attached azobenzene switches and their uses for the optical control of target proteins
Maji et al. Potential Antileishmanial activity of a triazole‐based hybrid peptide against Leishmania major
Kanfar et al. Effective access to multivalent inhibitors of carbonic anhydrases promoted by peptide bioconjugation
Vallade et al. Assessing interactions between helical aromatic oligoamide foldamers and protein surfaces: a tethering approach
EP1297001A1 (fr) Peptides lineaires amphipathiques et les compositions les contenant
Surís-Valls et al. Inhibition of ice recrystallization by nanotube-forming cyclic peptides
CA2383086A1 (en) Non-peptidic cyclophilin binding compounds and their use
Bahatheg et al. Short tryptamine-based peptoids as potential therapeutics for microbial keratitis: Structure-function correlation studies
Van der Poorten et al. Indoloazepinone‐Constrained Oligomers as Cell‐Penetrating and Blood–Brain‐Barrier‐Permeating Compounds
Trant et al. Synthesis, self-assembly, and immunological activity of α-galactose-functionalized dendron–lipid amphiphiles
Chen et al. Fast and Facile Synthesis of 4-Nitrophenyl 2-Azidoethylcarbamate Derivatives from N-Fmoc-Protected α-Amino Acids as Activated Building Blocks for Urea Moiety-Containing Compound Library
Kalariya et al. New Amino Acids Naphthalene Scaffolds as Potent Antimicrobial Agents: In Vitro Assay and In Silico Molecular Docking Study
Sikora et al. Quaternary Ammonium Salts of Cationic Lipopeptides with Lysine Residues—Synthesis, Antimicrobial, Hemolytic and Cytotoxic Activities
Bahatheg et al. Short tryptamine-based peptoids as potential therapeutics for microbial keratitis: Structure-function correlation studies. Antibiotics (basel) 2022; 11 (8): 1074
Tran et al. Evaluation of Peptide Ligation Strategies for the Synthesis of the Bivalent Acid-Sensing Ion Channel Inhibitor Hi1a
WO2022074313A1 (fr) Nouveaux peptoides et leur utilisation dans la prevention ou le traitement de la douleur chronique
Orgren Calabretta Guanidinium Compounds: Synthesis, Oxoanion Binding, and Cellular Delivery

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20221003